Company News

The world's first phase III clinical data of COVID-19 inactivated vaccines is officially released


One May 26,The Journal of the American Medical Association, JAMA,IF45.54 published the “Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults” by China National Biotec Group(CNBG) of China National Pharmaceutical Group Co., Ltd. (Sinopharm).The report summarizes and analyzes the effectiveness and safety of the Phase III clinical trial of the novel crown inactivated vaccine (Ⅲ) from Beijing Institute of Biological Products (BIBP), Wuhan Institute of Biological Products (WIBP) of China National Biotec Group(CNBG) Phase III of the new crown inactivated vaccines. 

This is the world's first officially published phase III clinical trial results of a COVID-19 inactivated vaccines Ⅲ, and it is also the first published clinical trial results of a COVID-19 inactivated vaccines in the normal phase in China.
Contact us now
Shanghai Chemtron Biotech Co., Ltd.
No.518 Qingdai Rd., International Medical Park,Pudong, 201318 Shanghai,PEOPLE’S REPUBLIC OF CHINA.
You can trust us
We are a professional manufacturer in China. We continue to innovate so that our customers can have better products and services.
© Shanghai Chemtron Biotech Co., Ltd.         Terms & Conditions        Privacy     
Enter your inquiry details and we will reply to you within 24 hours.
Name cannot be empty
Mailbox cannot be empty
Mobile phone cannot be empty
Information cannot be empty